Understanding evidence-based clinical practice guidelines for cholelithiasis 2021  

作　　者：Dushyant Singh Dahiya Antonio Facciorusso Saurabh Chandan Amir Humza Sohail Manesh Kumar Gangwani Gianluca Franchellucci Benedetto Mangiavillano 

机构地区：[1]Division of Gastroenterology,Hepatology&Motility,The University of Kansas School of Medicine,Kansas City,KS,USA [2]Gastroenterology Unit,Department of Biomedical Science,Foggia University Hospital,Foggia,FG,Italy [3]Division of Gastroenterology and Hepatology,Creighton University School of Medicine,Omaha,NE,USA [4]Complex Surgical Oncology,Department of Surgery,University of New Mexico,Albuquerque,NM,USA [5]Department of Gastroenterology and Hepatology,University of Arkansas for Medical Sciences,Little Rock,AR,USA [6]Digestive Endoscopy,IRCCS Humanitas Research Hospital,Rozzano,MI,Italy [7]Department of Biomedical Sciences,Humanitas University,Pieve Emanuele,MI,Italy [8]Gastrointestinal Endoscopy Unit,Humanitas-Mater Domini,Castellanza,VA,Italy

出　　处：《Hepatobiliary Surgery and Nutrition》2024年第2期352-355,共4页肝胆外科与营养（英文）

摘　　要：Cholelithiasis is characterized by impaired metabolism of bile acids,cholesterol and bilirubin resulting in deposition of gallstones within the gallbladder(1).The article by Fujita et al.outlines the third revision of the evidence-based practice guidelines issued by the Japanese Society of Gastroenterology(JSGE)on cholelithiasis(2).For these current guidelines,52 questions were adopted through discussions among committee members,covering epidemiology,pathogenesis,diagnosis,treatments,complications,and prognostic aspects of cholelithiasis in Japan(2).The strengths of recommendations were determined by voting by committee members after assessing current available literature,patient preferences,and cost-benefit balance(2).Similar to the previous guideline(second revision),consensus among committee members was defined as the acquisition of 70%votes or over(2).

关 键 词：CHOLECYSTECTOMY GALLBLADDER CHOLELITHIASIS endoscopic ultrasonography(EUS) CHOLECYSTITIS CHOLANGITIS 

分 类 号：R657.42[医药卫生—外科学]